Patents by Inventor Eugene B. Grant, III

Eugene B. Grant, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES
    Publication number: 20090156577
    Abstract: The present invention relates to compounds having a structure according to Formula (I) wherein n, m, z, R, R2, R3, R4, R5, R6, A, E, X, Y, a and b are as defined above; or an optical isomer, diastereomer or enantiomer thereof; a pharmaceutically acceptable salt, hydrate, or prodrug thereof.
    Type: Application
    Filed: November 11, 2008
    Publication date: June 18, 2009
    Inventors: Benjamin Davis, Eugene B. Grant, III, Shu-Chen Lin, Mark J. Macielag, Michele Ann Weidner-Wells, Xiaoqing Xu, Xiaodong Xu, Bin Zhu
  • 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
    Patent number: 7179805
    Abstract: The present invention relates to compounds having a structure according to Formula I wherein n, m, z, R, R2, R3, R4, R5, R6, A, E, X, Y, a and b are as defined above; or an optical isomer, diastereomer or enantiomer thereof; a pharmaceutically acceptable salt, hydrate, or prodrug thereof.
    Type: Grant
    Filed: September 9, 2004
    Date of Patent: February 20, 2007
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Eugene B. Grant, III, Mark J. Macielag, Xiaoqing Xu, Steven David Paget, Michele Ann Weidner-Wells
  • 6-O-carbamate-11,12-lacto-ketolide antimicrobials
    Patent number: 6713455
    Abstract: 6-O-Carbamate-11,12-lacto-ketolide antimicrobials of the formula: wherein R1, R2, R3 R7, and R8 are as described herein and in which the substituents have the meaning indicated in the description. These compounds are useful as antibacterial agents.
    Type: Grant
    Filed: September 16, 2002
    Date of Patent: March 30, 2004
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Eugene B. Grant, III, Todd C. Henninger, Mark J. Macielag, Deodialsingh Guiadeen